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downregulates Cdc42 to suppress
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required for neuronal migration and
neuritogenesis in the developing brain.
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Mutations in the Autism susceptibility candidate 2
gene (AUTS2), whose protein is believed to act in
neuronal cell nuclei, have been associated with multi-
ple psychiatric illnesses, including autism spectrum
disorders, intellectual disability, and schizophrenia.
Here we show that cytoplasmic AUTS2 is involved
in the regulation of the cytoskeleton and neural devel-
opment. Immunohistochemistry and fractionation
studies show that AUTS2 localizes not only in nuclei,
but also in the cytoplasm, including in the growth
cones in the developing brain. AUTS2 activates Rac1
to induce lamellipodia but downregulates Cdc42 to
suppress filopodia. Our loss-of-function and rescue
experiments show that a cytoplasmic AUTS2-Rac1
pathway is involved in cortical neuronal migration
and neuritogenesis in the developing brain. These
findings suggest that cytoplasmic AUTS2 acts as a
regulator of Rho family GTPases to contribute to brain
development and give insight into the pathology of
human psychiatric disorders with AUTS2mutations.
INTRODUCTION
The Autism susceptibility candidate 2 (AUTS2) gene was origi-
nally associated with autism spectrum disorders (ASDs) in a
study that described a de novo balanced translocation disrupt-
ing the AUTS2 locus in a pair of monozygotic twins (Sultana
et al., 2002). Thereafter, more than 30 unrelated patients with
multiple neuropsychiatric disorders such as ASD, intellectual
disability (ID), attention deficit hyperactivity disorder, dyslexia,
and epilepsy as well as developmental delay (DD), visual impair-
ment, and microcephaly have been shown to carry distinct het-
erozygous disruptions of the AUTS2 locus (Bakkaloglu et al.,
2008; Ben-David et al., 2011; Elia et al., 2010; Glessner et al.,2166 Cell Reports 9, 2166–2179, December 24, 2014 ª2014 The Aut2009; Huang et al., 2010; Kalscheuer et al., 2007; Pinto et al.,
2010; Talkowski et al., 2012). In addition, 24 exonic microdele-
tions were identified in the AUTS2 gene in individuals with
various psychiatric disorders (Beunders et al., 2013). Moreover,
very recent studies suggested that this gene is also associated
with schizophrenia (Zhang et al., 2014; McCarthy et al., 2014).
The wide spectrum of phenotypes observed in patients with
AUTS2 mutations suggests that this gene is not associated
with a specific type of ASD but with a broader range of psychiat-
ric disorders, thus highlighting AUTS2 as a current gene of inter-
est (Oksenberg and Ahituv, 2013).
AUTS2 encodes a relatively large protein (AUTS2 protein,
1,259 amino acids in human). In addition to two proline-rich re-
gions (PR1 and PR2), AUTS2 possesses motifs that suggest
nuclear localization, including a few putative nuclear localizing
sequences, eight histidine repeats, and one predicted PY motif
(Oksenberg and Ahituv, 2013; Salichs et al., 2009; Zhi and
Chen, 2012) (Figure 2C). Moreover, immunostaining as well as
forced expression of AUTS2 protein in cultured cells revealed
nuclear localization of this protein (Bedogni et al., 2010b), which
led many scientists to believe that AUTS2 functions in cell nuclei
(Oksenberg and Ahituv, 2013).
In the developing mouse brain, Auts2 is highly expressed in
many regions such as the frontal cortex, hippocampus, and cer-
ebellum (Bedogni et al., 2010a, 2010b; Lancaster et al., 2013),
key areas for high order brain functions. However, little is known
with regard to the physiological role of AUTS2, due to lack of
functional analysis for this gene, except for a few studies in ze-
brafish. In zebrafish,Auts2 is highly expressed in the brain during
development (Beunders et al., 2013; Oksenberg et al., 2013), and
knockdown of Auts2 by morpholino studies resulted in micro-
cephaly and reduction of neurons in embryos (Beunders et al.,
2013; Oksenberg et al., 2013). While these results suggest that
AUTS2 functions in cell proliferation, survival, and maturation
of neurons in zebrafish, it did not explain the pathology of psychi-
atric patients with AUTS2 mutations. Therefore, we suspected
AUTS2 might have other functions in the mammalian brain,
which might be more directly linked with the phenotypes ofhors
Figure 1. AUTS2 Expression in the Devel-
oping Cerebral Cortex
(A) Triple-immunofluorescent staining of AUTS2
with postmitotic neuronal markers HuC/D and Tuj1
or proliferating cell marker Ki67 in E12.5 mouse
cerebral cortex.
(B) Immunostaining of E14.5 mouse cerebral cor-
tex shows the colocalization of AUTS2 with Tuj1 in
CP (arrowheads) and DCX in the IZ.
(C) Immunostaining for AUTS2 and the layer-spe-
cific marker Cux1 (upper layer; left) and Ctip2
(deep layer; right) at P0 mouse neocortex.
(D) In P7 mouse neocortex, AUTS2 is specifically
expressed in glutaminase (Glu)-positive excitatory
but not GABA-expressing inhibitory neurons.
(E) Expression of AUTS2 protein in brain devel-
opment; 30 mg of neocortical lysates were blotted
with anti-AUTS2 Ab.
PP, preplate; SVZ: sub-VZ. Scale represents
50 mm. See also Figure S1.psychiatric disorders. To uncover the physiological roles of
AUTS2 in brain development, we investigated its molecular
properties in neurons in the developing cerebral cortex.
RESULTS
Localization of AUTS2 in the Brain
Western blotting analysis with an antibody against AUTS2
(1,016–1,116 amino acids) revealed that the expected full-length
(FL) mouse AUTS2 protein (approximately 140 kDa) initially ap-Cell Reports 9, 2166–2179, Depears in the cerebral cortex at early
embryonic stages (E12.5) and continues
throughout development (Figure 1E).
This antibody also detected an additional
shorter band (100 kDa), which was tran-
siently expressed in early development,
plateaued at E14.5, and was undetect-
able postnatally. The molecular weight
for the short band matches that of a short
isoform of AUTS2 predicted by UCSC
(the University of California Santa Cruz)
Genome bioinformatics. Immunohisto-
chemistry of the developing mouse cere-
bral cortex at E12.5 showed that AUTS2
colocalized with HuC/D and Tuj1,
markers for postmitotic neurons, but not
with the proliferating cell marker Ki67 in
the ventricular zone (VZ) (Figure 1A).
In early embryonic stages, AUTS2 is
exclusively found in nuclei of preplate
neurons (Figure 1A). At later stages, how-
ever, AUTS2 is also detected in neurites
labeled by Tuj1 at the cortical plate (CP)
as well as in doublecortin (DCX)-positive
axonal tracts of projection neurons in
the intermediate zone (IZ) (Figure 1B).
Postnatally, AUTS2 is broadly expressed
in the CP from deep- to upper-layer neu-rons (Figure 1C). We also found that AUTS2 is specifically ex-
pressed in glutamatergic neurons but not GABAergic inhibitory
neurons in the cerebral cortex (Figure 1D). In the hippocampus,
AUTS2 is expressed in glutamatergic neurons such as pyramidal
neurons and granule cells, but not in GABAergic inhibitory neu-
rons (data not shown).
Although previous studies implied that AUTS2 is a nuclear pro-
tein (Bedogni et al., 2010b; Sultana et al., 2002), our immunohis-
tochemical observations suggested that AUTS2 localizes in both
nuclear and extranuclear regions. To further characterize thecember 24, 2014 ª2014 The Authors 2167
Figure 2. Rac1-Dependent Lamellipodia Formation by FL-AUTS2
(A) Immunocytochemistry of primary hippocampal neurons at DIV1 shows the localization of AUTS2 at growth cones.
(B) FL-AUTS2 induces lamellipodia in N1E-115 cells that is suppressed by coexpression of N17Rac1. Graph shows the percentage of cells with lamellipodia in
total cells transfected.
(legend continued on next page)
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subcellular localization of AUTS2, fractionated brain lysateswere
prepared from E18.5 mouse cerebral cortices. Immunoblot data
revealed that FL-AUTS2 bands were present not only in nuclei
but also in the cytoplasmic fraction as well as the cytoskel-
eton-containing insoluble fractions (Figure S1C). In contrast,
the shorter band was exclusively found in the nucleic fraction
(Figure S1C). This suggests that the FL-AUTS2 localizes in
both nuclear and extranuclear subcellular regions in contrast
with the nuclear-specific short isoform.
In primary cultured hippocampal neurons, AUTS2 was
observed not only in the nuclei but also in neurites and cytoplasm
(Figure 2A, left). In particular, AUTS2 appeared to accumulate at
actin-rich growth cones (Figure 2A, right). Consistent results
were observed in primary cortical neurons (data not shown).
We also confirmed that another anti-AUTS2 antibody showed
similar immunofluorescence patterns (data not shown, see
Experimental Procedures). In the neuroblastoma N1E-115 cell
line, punctate AUTS2 immunostaining was also detected in
growth cones partially colocalized with Rac1, a member of the
Rho family small GTPases (Figure S1A). Furthermore, the labeled
AUTS2 immunoclusters were maintained after in situ extraction
with Triton X-100 in N1E-115 cells, suggesting that AUTS2 is
associated with the cytoskeleton (Figure S1B). This is consistent
with the detection of FL-AUTS2 in the cytoskeleton-containing
insoluble fractions (Figure S1C). These findings suggested that
AUTS2, in particular the full-length isoform, may have a cyto-
plasmic role in cytoskeletal regulation, in addition to its nuclear
function.
AUTS2 Regulates Rho-family GTPases
In the presence of serum, N1E-115 cells usually appear spherical
in shape (Figure 2B). Overexpression of FL-AUTS2, however,
dramatically induced lamellipodia, similar to cells expressing
an active Rac1 (V12Rac1) (Figure 2B). In contrast, coexpression
of FL-AUTS2 with a dominant-negative Rac1 (N17Rac1) sup-
pressed AUTS2-dependent lamellipodial formation (Figure 2B).
Furthermore, we observed the activation of endogenous Rac1
in FL-AUTS2-overexpressed N1E-115 cells using GTPase pull-
down assays (Figure S2A;DN-STEFwas used as positive control
for activation for Rac1) (Matsuo et al., 2002). These results sug-
gest that FL-AUTS2 acts as an upstream positive regulator of
Rac1 in the regulation of actin cytoskeleton.
We next expressed a series of AUTS2 deletionmutant proteins
in N1E-115 cells. Only mutant AUTS2 proteins containing the
N-terminal PR1 region (288–471 amino acids) such as AUTS2-
N1, AUTS2-DN, and AUTS2-M2 exhibited lamellipodia formation
to a similar extent as FL-AUTS2 (Figures 2C and 2D), suggesting
that the PR1 region is important for the regulation of actin remod-
eling. AUTS2 deletion mutants that lack a PR1 domain, including
AUTS2-Var.2 (corresponding to a short isoform of AUTS2, as(C and D) Determination of the functional domain of AUTS2 for lamellipodia for
constructs. PR, proline-rich region; PY, PY motif; His, eight histidine repeats. (D) N
scored as a percentage of the total number of transfected cells (n > 500 cells fro
(E) Subcellular localization ofMyc-tagged AUTS2 variants and its truncatedmutan
(see Figure S3F).
Data are means ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, t test. Scale bar repres
and S2.
Cell Redescribed below; see Figure S5), did not exhibit the lamellipo-
dia-inducing ability.
We examined the subcellular localization of the recombinant
AUTS2 and its deletion mutant proteins in differentiated N1E-
115 cells. FL-AUTS2 is localized in the cytoplasm, including neu-
rites and growth cones, as well as nuclei (Figure 2E), exhibiting
immunostaining patterns similar to endogenous AUTS2 (Figures
2A, S1A, and S1B). The AUTS2-N1 mutant exhibited the same
distribution patterns as FL-AUTS2, whereas the AUTS2 short-
form variant (lacking the N terminus as described below;
AUTS2 variant 2; see Figure S5) and AUTS2-C2 were exclusively
nuclear (Figure 2E). Interestingly, the AUTS2-M2 mutant, which
is a minimal fragment for lamellipodia induction, was mainly
cytoplasmic, with some slight nuclear localization observed (Fig-
ure 2E). To further investigate the cytoplasmic function of
AUTS2, we fused a nuclear export sequence (NES) derived
from MAPKK at the N terminus of FL-AUTS2 (NES-FL-AUTS2).
We found that NES-FL-AUTS2 is exclusively localized in the
cytoplasm of N1E-115 cells (Figure 2E). NES-FL-AUTS2 ex-
hibited greater lamellipodia-inducing activity compared with
FL-AUTS2 in N1E-115 cells (Figure 2D, p = 0.04 versus FL-
AUTS2). These findings revealed a correlation of ‘‘lamellipodia-
inducing ability’’ and ‘‘cytoplasm localizing ability’’ among the
mutant proteins and therefore suggest that cytoplasmic AUTS2
may induce lamellipodia via activation of Rac1. Furthermore,
these results imply that PR1 is a critical region for Rac1 activation
and cytoplasmic localization.
It has been reported that Rac1 is activated by a variety of gua-
nine nucleotide-exchange factors (GEFs), including STEF,
Tiam1, P-Rex1, and Dock180/Elmo2 complex (Buchsbaum,
2007; Matsuo et al., 2003; Yoshizawa et al., 2005). While DN
forms for P-Rex1 (DDH-P-Rex1), Elmo2 (Elmo2-DN), and
Dock180 (Dock180-ISP) suppressed FL-AUTS2-induced lamel-
lipodia in N1E-115 cells, DN forms for STEF and Tiam1 (STEF-
PHnTss) did not (Figure S2B) (Katoh and Negishi, 2003; Matsuo
et al., 2002; Yoshizawa et al., 2005). Furthermore, we confirmed
by immunoprecipitation experiments that FL-AUTS2 interacts
with P-Rex1 and the Elmo2/Dock180 complex (Figures 3D
and 3E), but not STEF or Tiam1 (data not shown). These results
suggest that FL-AUTS2 can activate Rac1 via interaction with
P-Rex1 and the Elmo2/Dock180 complex to regulate actin
dynamics in N1E-115 cells.
As was observed in N1E-115 cells, we found that introduction
of FL-AUTS2 caused an increase in the Rac1 activity in primary
hippocampal neurons (Figure 3A). We previously demonstrated
that the activation of the Rac1 signaling pathway in primary hip-
pocampal neurons promotes neurite outgrowth (Nishimura et al.,
2005). Consistently, at 4 days in vitro (DIV4), primary hippocam-
pal neurons transfected with FL-AUTS2 had longer neurites
compared with the control neurons; this could be suppressedmation. (C) Schematic diagram of mouse FL-AUTS2 and the deletion mutant
1E-115 cells were transfected with indicated plasmids. Cells with lamellipodia
m three to six independent experiments for each construct).
ts in the differentiated N1E-115 cells. AUTS2-Var.2, AUTS2 short-form variant 2
ents 20 mm (A, B, and E) and 5 mm (E, high magnifications). See also Figures S1
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Figure 3. FL-AUTS2 Induces Neurite Elon-
gation via Activating Rac1
(A) Rac1 activity in primary cultured cortical
neurons at DIV7, transduced with control or FL-
AUTS2 expression plasmid, was analyzed by
GST-CRIB pull-down assay.
(B) Representative images of primary hippocam-
pal neurons at DIV4 coelectroporated with control
or FL-AUTS2 plus GFP expression vector.
(C) Effects of the dominant-negative forms for
Rac1 and its upstream regulators on AUTS2-
induced neurite outgrowth. The length of the
longest neurite was measured in primary cultured
hippocampal neurons transfected with the indi-
cated vectors at DIV4 (n = 80100 neurons).
(D and E) Interaction of AUTS2 and Rac-GEFs.
HEK293T cell lysates transfected with the indi-
cated plasmids were immunoprecipitated with an
antibody against Myc. The precipitants were
analyzed with anti-GFP, Myc, HA, and FLAG an-
tibodies, respectively.
All graphs are mean ± SEM of at least three inde-
pendent experiments. *p < 0.05, **p < 0.01, ***p <
0.001, t test. Scale bar represents 20 mm. See also
Figure S2.by cointroduction of DN-Rac1 (Figures 3B and 3C). Furthermore,
this neurite outgrowth-inducing ability of FL-AUTS2was blocked
by cotransfection of the DN form for Elmo2 but not by that for
P-Rex1 or STEF/Tiam1 (Figure 3C). These findings suggest
that FL-AUTS2 can induce neurite outgrowth of primary hippo-
campal neurons through the activation of the Elmo2/Dock180-
Rac1 pathway.
Physiological Roles of AUTS2 in Neuritogenesis and
Neuronal Migration
We prepared shRNA constructs specifically targeting FL-Auts2
mRNA (Figure S5F) that effectively downregulated expression
of FL-AUTS2 but not the short isoform (Figures S3A and S3B).
The shRNA and GFP expression vectors were cointroduced
intomouse embryonic brains by in utero electroporation (Kawau-
chi et al., 2003) at E15.5, and dissociated cortical neurons were
prepared at E16.5 and cultured for DIV2 to DIV6. In the Auts2
shRNA-expressing neurons, the length and branch number of
axons and dendrites were dramatically reduced (Figures 4A
and 4B). The impairment of neurite formation was, however,
restored by the expression of the shRNA-resistant FL-AUTS2
(FL-AUTS2R), indicating that such a defect is the result of specific
knockdown of Auts2. The impairment of neurite formation by
Auts2 knockdown was also reversed by WT Rac1 (Figure 4B).
Together with the fact that AUTS2 has the ability to promote
neurite extension by activating Rac1 (Figure 3C), these results2170 Cell Reports 9, 2166–2179, December 24, 2014 ª2014 The Authorssuggest that AUTS2 regulates neurito-
genesis via activation of Rac1 signaling.
Moreover, all GFP-positive cells
showed immunoreactivity with Tuj1, a
neuronal marker, indicating that misspe-
cification to other cell types such as glial
cells by Auts2-silencing does not occur(data not shown). Similarly, introduction of short interfering
RNAs (siRNAs) resulted in inhibition of neurite outgrowth in
N1E-115 cells that normally elongate neurites in serum-free me-
dia (Figure 4C). These findings suggest that AUTS2 is required
for neurite extension and branch formation.
Interestingly, in both primary cortical neurons and N1E-115
cells where Auts2 was knocked down, filopodia-like protrusions
were extensively formed at the cell periphery and neurites
(Figures 4D and 4E). Filopodia formation in those cells was effec-
tively suppressed by introduction of siRNA for another Rho-
family GTPase, Cdc42 (Figures 4F and S3B), a well-known key
molecule for filopodial formation (Etienne-Manneville and Hall,
2002). Furthermore, introduction of siRNA for either (or both) In-
tersectin 1 (ITSN 1) and ITSN 2, which are GEFs specific for
Cdc42 (Hunter et al., 2013), also suppressed the filopodia forma-
tion induced by Auts2 knockdown (Figures S3C and S3D). In
addition, GTPase pull-down assays revealed upregulation of
Cdc42 activity in the Auts2-knockdown N1E-115 cells (Fig-
ure 4G). These results suggest that AUTS2 acts as an inhibitory
factor against Cdc42 signaling for filopodia formation, presum-
ably via suppression of ITSN 1 and ITSN 2. Thus, this molecule
seems to have the very unique property of inversely regulating
the activities of Rac1 and Cdc42. However, because the physio-
logical relevance of AUTS2 in suppressing Cdc42 is unclear as
described below,we do not focus on the AUTS2-Cdc42 pathway
in this manuscript.
We then introduced Auts2 shRNA with a GFP indicator into
mouse embryonic cerebral cortices at E14.5 by in utero electro-
poration. At P0, in control brains, more than 80% of neurons
have migrated into layers II–IV of the CP (Figure 5A). However,
the majority of the shRNA-expressing cells were observed to
exhibit a drastic migratory defect (Figure 5A). This abnormality
could be rescued by not only FL-AUTS2 but also by NES-FL-
AUTS2 (Figure 5A). These facts indicate that cytoplasmic
AUTS2 is involved in cortical neuronal migration.
During the early migration process from lower IZ (loIZ) to upper
IZ (uIZ) at E17.5, cortical neurons usually transform from multi-
polar to spindle-like bipolar shapes with a long leading process
extending along radial glial fibers (Noctor et al., 2004; Tabata
and Nakajima, 2003) (arrows in Figure 5B). However, in the
shRNA-expressing neurons in uIZ and CP, the leading process
appeared twisted and irregular with branching (arrowheads in
Figure 5B). It has been reported that Rac1 not only regulates
actin cytoskeleton but also activates JNK in migrating neurons
in the IZ (Kawauchi et al., 2003). While activated JNK (phosphor-
ylated-JNK) was strongly observed in migrating neurons in the IZ
of control cortices at E17.5, it was almost completely absent in
shRNA-introduced neurons (Figure 5C), suggesting that Rac1
signaling is downregulated in those migrating neurons, although
we cannot exclude the possibility that AUTS2 may regulate the
activation of JNK via the Rac1-independent signaling pathway.
As P-Rex1 was previously found to participate in cortical
neuronal migration by activating Rac1 (Yoshizawa et al., 2005),
and because AUTS2 can activate Rac1 via P-Rex1 (Figure S2B),
these findings may imply that in migrating neurons AUTS2
activates the P-Rex1-Rac1 pathway to elicit normal cortical
neuronal migration.
We subsequently performed coimmunostaining of GFP with
cortical layer-specific markers in the shRNA-introduced brain
sections. Almost all the shRNA-expressing cells in the deep-
layer expressed Cux1, a marker for upper cortical layer neurons
(Figures 5D and S3F). In contrast, we did not find any GFP-pos-
itive cells expressing Ctip2, a marker for deep-cortical layer
neurons in the brain sections electroporated with the scramble
or Auts2 shRNA (Figure S3E; n = 400 cells were counted from
four embryos). Moreover, there was no colocalization of
shRNA-expressing cells with cleaved caspase 3, an apoptotic
cell death marker (data not shown). These findings suggest
that knockdown of Auts2 affected neither neuronal layer identity
nor cell survival.
Generation of Mouse Auts2 Mutants
To genetically investigate the role of AUTS2 in vivo, we engi-
neered knockout (KO) mice in which exon 8 of the Auts2 gene
can be removed by Cre-recombinase activity, creating a frame-
shift mutation that would disrupt coding for the downstream
portion of AUTS2 containing the PR1 region (Figures S4A and
S5A). Information from various databases and previous papers
indicated that the shorter AUTS2 band likely corresponded
to a splicing variant (variant 1; Figure S5F) originating from a
translational start site (ATG) in the middle of exon 8. We pre-
dicted that this targeting strategy would knock out both FL-
Auts2 and the short isoforms. Surprisingly, we found that both
FL and shorter AUTS2 proteins were almost completely elimi-Cell Renated in homozygotes of Auts2neo (Auts2neo/neo; Figure S5C),
which still possessed exon 8 plus the pgk-neo selection cassette
in the genome (Figure S4A). Consistent with this, we could
barely detect AUTS2 protein by immunohistochemistry in the
Auts2neo/neo brains (Figure S5D). AUTS2 was decreased by
50% in heterozygotes compared with WT mice (Figure S5C).
The reduction of AUTS2 in this allele is likely caused by insertion
of the pgk-neo cassette into intron 9 because excision of the
cassette by FLP recombinase (Auts2flox allele) rescued the ex-
pression of AUTS2 (Figures S4A and S5C). Therefore, we used
Auts2neo as a strong loss of function allele for Auts2 in this study.
Next we generated an Auts2del8 allele, which lacks exon 8, by
crossing Auts2flox mice with Cre recombinase mice (CAG-Cre;
Figures S4A and S5B). As expected, the FL-AUTS2 was
completely eliminated in the homozygous brain (Auts2del8/del8;
Figure S5C). However, the expression level of an AUTS2 short
isoform was alternatively increased, which was also observed
in heterozygotes (Auts2del8/+; Figure S5C). Beunders et al.
(2013) recently identified a short 30 human AUTS2 mRNA tran-
script that originates from the middle of exon 9. We confirmed
by 50 rapid amplification of cDNA ends analysis (50RACE) the ex-
istence of a similar transcriptional start site in exon 9 (variant 2) in
the mouse brain, in addition to the previously predicted start site
in exon 7 (variant 1; Figures S5E–S5G). According to our exper-
imental design (Figure S4A), the Auts2del8 allele should express
variant 2 but not variant 1, suggesting that the strongly detected
shorter band probably corresponds to variant 2.We suspect that
loss of the FL Auts2 may lead to compensatory enhanced
expression of the short variant 2, although we lack direct
evidence.
Developmental Abnormalities in Auts2 Mutants
Because homozygotes of both lines (Auts2neo/neo and
Auts2del8/del8) were neonatally lethal, we examined their embry-
onic brains. There were no gross morphological or histological
differences between brains from Auts2neo or Auts2del8 mutants
and WT embryos (Figure S4B, data not shown). A previous
study demonstrated the involvement of Auts2 in the regulation
of cell proliferation and neuronal differentiation in zebrafish (Be-
unders et al., 2013). To determine whether Auts2 deficiency in
mice also affects these developmental events, we examined
the cell cycle exit rate in the developing cerebral cortices of
Auts2 mutant mice. E15.5 brain sections were prepared 24 hr
after pulse labeling with 5-ethynyl-20-deoxyuridine (EdU) and
costained with Ki67 (Figure S4C). The number of cells that
remain in progenitor state in the VZ was quantified by counting
the EdU+Ki67+ cells. As shown in Figures S4D and S4E, there
was no significant difference in the rate of cell cycle exit or
the thickness of VZ between WT and Auts2 mutant mice
(Auts2neo/neo or Auts2del8/del8). Together with the observation
that AUTS2 is not expressed in proliferating cells in the VZ (Fig-
ures 1A and 1B), these findings suggest that AUTS2 is not
involved in the proliferation of progenitor cells in the mouse
cerebral cortex.
To estimate neuronal migration, pregnant mice with E14.5 em-
bryos were injected with bromodeoxyuridine (BrdU), and em-
bryos were harvested at E18.5. We found that a significant
proportion of the BrdU-positive cells abnormally remained inports 9, 2166–2179, December 24, 2014 ª2014 The Authors 2171
Figure 4. Knockdown of Auts2 Affects Neural Morphogenesis
(A) Primary cortical neurons cotransfected with Auts2-shRNA or control-shRNA and GFP vector.
(B) The measurement of neurite length and number of branching points of individual neurons (n = 30 neurons). Expression of the shRNA-resistant FL-AUTS2
(FL-AUTS2R) or Rac1-WT restores the impairment of neurite formation in Auts2-deficient neurons.
(C) Knockdown of Auts2 with siRNA suppresses the neurite elongation of N1E-115 cells induced by serum starvation. Cells with neurites were scored as a
percentage of the total number of transfected cells (n > 500 cells from three independent experiments).
(D and E) Auts2 knockdown induces F actin (phalloidin) but not tubulin (Tuj-1)-based filopodia-like protrusions (white arrows) in primary cortical neurons (D) at
DIV2 and N1E-115 cells (E).
(legend continued on next page)
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the deep layer of Auts2neo heterozygous and homozygous
mutant brains at E18.5 in a gene dose-dependent manner (Fig-
ure S6), suggesting that Auts2 is involved in cortical neuronal
migration. Cerebral cortices of Auts2del8 mutants electroporated
in utero with a GFP vector at E14.5 were subsequently examined
at E18.5 for the distribution of GFP-positive neurons. In WT
cortices, a large portion of GFP-positive neurons reached layers
II–IV within 4 days of labeling, whereas a considerable number
of neurons exhibited migration defects in Auts2del8/+and
Auts2del8/del8mutant brains in a gene dosage-dependent manner
(Figure 6A). Because the short isoform of AUTS2 (variant 2) is
maintained in the homozygous Auts2del8/del8 brains (Figure S5C),
this result indicates that FL-AUTS2, but not variant 2, is involved
in cortical neuronal migration. Accordingly, this phenotype was
clearly rescued by electroporation of a FL-AUTS2 vector
(Figure 6A).
To further investigate the physiological significance of AUTS2-
Rac1 signaling in neuronal migration, we performed the coelec-
troporation of a Cre recombinase vector into Auts2flox/flox brains
with a series of AUTS2 deletion constructs and small GTPase
expression vectors. Consistent with the results observed in the
Auts2del8/del8 brains, the acute deletion of Auts2 by Cre recombi-
nase in Auts2flox/flox brains recapitulated neuronal migration de-
fects, as expected. Interestingly, this abnormality was rescued
not only by FL-AUTS2 but also WT-Rac1 (Figure 6B), indicating
that the AUTS2-Rac1 pathway is involved in cortical neuronal
migration. Consistently, a short AUTS2-M2 mutant protein that
can induce lamellipodia is also able to rescue the migration de-
fects, while AUTS2-DPR1, lacking the lamellipodia-inducing
ability, failed to rescue the phenotype (Figure 6B). The migration
phenotype was not rescued by expression of the DN form for
Cdc42 (N17Cdc42) (Figure 6B). This implies that the inhibitory
effect of AUTS2 against Cdc42 does not play an important role
in the regulation of neuronal migration.
Next, we examined the contralateral projecting axons of layer
II/III cortical neurons of embryos electroporated at E14.5. In
E18.5 WT brains, GFP-labeled axons were elongated and found
to cross the midline to reach the contralateral cortex. In contrast,
Auts2del8/+ and Auts2del8/del8 mutant brains exhibited severe
impairment of axonal elongation in a gene-dosage dependent
manner (Figure 7A), suggesting that the FL-AUTS2 is required
for elongation of the cortical commissural axons. The axonal
elongation defects were also observed in Auts2flox/flox brains
electroporated with the Cre-expression vector (Figure S7).
Consistent with the neuronal migration results in Figure 6B, this
abnormality was rescued by FL-AUTS2, AUTS2-M2, and WT-
Rac1, but not by AUTS2-DPR1 or DN-Cdc42 (Figure S7). These
findings strongly suggest that AUTS2 activation of Rac1 is
involved in cortical axonal elongation in vivo.
Next, cortical neurons of embryonic brains were labeled with
GFP at E15.5 by in utero electroporation and harvested at
E16.5. When cultured in dissociated cell culture in vitro for(F) Simultaneous knockdown of Auts2 and Cdc42 suppresses the filopodia forma
total number of transfected cells indicated by GFP (n = 3, more than 500 cells p
(G) Lysates from N1E-115 cells transfected with indicated constructs were incuba
Cdc42 (n = 3).
All graphs are means ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, t test. Scale bar
Cell Re6 days, the length and branch number of putative axons and den-
drites in GFP-positive neurons were significantly reduced in
Auts2del8/+ and Auts2del8/del8 in a gene dose-dependent manner
(Figure 7B), confirming that AUTS2 is required for neuritogenesis
in a cell autonomous manner.
DISCUSSION
Although the AUTS2 protein is generally believed to reside and
function in cell nuclei, we found that AUTS2 also localizes extra-
nuclearly, in regions such as the cytoplasm of processes and cell
bodies of neurons, as a regulator of Rho family small G protein
signaling. In our protein fractionation study, we detected a
considerable amount of FL-AUTS2 in the cytoplasmic as well
as the cytoskeleton-containing insoluble fractions, while the
shorter isoform was found only in the nucleic fraction. Immuno-
histochemical staining of the developing brain revealed that
AUTS2 was present not only in nuclei but also in the cytoplasm
and neurites, especially at the growth cone, partially colocalized
with Rac1. Furthermore, in situ extraction experiments revealed
that AUTS2 is associated with the cytoskeleton. These results
suggest that the AUTS2 protein, at least FL-AUTS2, is not always
predominantly nuclear but resides in extranuclear regions of
neurons.
We showed that FL-AUTS2 could activate Rac1 to induce
lamellipodia and neurite extension in N1E-115 cells and primary
hippocampal neurons, respectively. The former ability is
believed to be transmitted via P-Rex1 and Elmo/Dock180, while
the latter is via Elmo/Dock180. In addition, AUTS2 appears to
downregulate Cdc42 activity via suppression of INST1 and
INST2.
Cdc42 and Rac1 activities have been shown to be similarly
regulated by sequential activation pathways from Cdc42 to
Rac1 (Gonzalez-Billault et al., 2012). In contrast, AUTS2 uniquely
regulates Rac1 and Cdc42 activities in opposing directions in
neuronal cells. We suspect that this protein might be involved
in the fine tuning of morphological changes of specialized parts
in neurons, such as processes, where precise, fine, and distinct
control of Rac1 and Cdc42 activities as well as actin dynamics
may be required. However, although we have uncovered some
of the roles of AUTS2-Rac1 in neuronal migration and neurito-
genesis, the physiological relevance of the AUTS2-Cdc42
pathway remains to be determined.
Using protein deletion studies, we analyzed the relationship
between the protein structure, Rac1-activating/lamellipodia-
inducing ability, and the subcellular localization. Interestingly,
we found that the lamellipodia-inducing ability was restricted
to deletion proteins with cytoplasmic-localizing ability. More-
over, NES-FL-AUTS2, an exclusively cytoplasmic-localizing
FL-AUTS2, possesses lamellipodia-inducing ability. These find-
ings strongly indicate that AUTS2 can function extranuclearly to
induce cytoskeletal reorganization via Rac1 activation. Ourtion in N1E-115 cells. Graph shows the percentage of cells with filopodia, with
er experiment).
ted with GST-CRIB, and bound Cdc42 was detected with an antibody against
s represent (A, C, and F) 20 mm and (D) 10 mm. See also Figure S3.
ports 9, 2166–2179, December 24, 2014 ª2014 The Authors 2173
Figure 5. AUTS2 Is Necessary for Neocortical Neuronal Migration
(A) Cortical neuronal migration is impaired by knockdown of Auts2 with shRNA construct in P0 brains. This defect is rescued by expressing FL-AUTS2R and
NES-FL-AUTS2R. Distribution of GFP-positive cells in each region is presented by the percentage of total number of GFP-positive cells (n = 4 embryos).
(B) Effects of Auts2 knockdown on morphology of migrating neurons in E17.5 brain sections.
(C) Knockdown of Auts2 in cortical neurons suppressed the activation of JNK in IZ of E17.5 brains.
(D) The effect of Auts2 shRNA in neocortex at P0 as shown by immunostaining with anti-Cux1 antibody. All electroporation with indicated plasmids was
performed at E14.5.
Data are presented as the means ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, t test. Scale bar represents 50 mm. See also Figure S3.
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Figure 6. Impairment of Cortical Neuronal
Migration in Auts2-Deficient Mice
(A) Cortical brain sections at E18.5 prepared from
WT and Auts2del8 mutant mice electroporated with
GFP vector (upper) or coelectroporated with GFP
and FL-AUTS2 expression vectors at E14.5 (lower).
Nuclei of GFP-positive cells plotted with white dots
are shown in each right panel. The graph shows the
percentage of GFP+ cells in each of six bins versus
the total number of GFP+ cells.
(B) Cortical brain sections of E18.5 Auts2flox/flox
mice electroporated with GFP and/or Cre re-
combinase at E14.5 show that acute KO of Auts2
results in a defect in neuronal migration. Coex-
pression of FL-AUTS2, AUTS2-M2, or Rac1-WT,
but not AUTS2-DPR1 or N17Cdc42 can rescue this
defect. Graph shows the percentage of GFP+ cells
in each of four bins versus the total number of GFP+
cells.
Data are presented as the mean ± SEM (n = 4). *p <
0.05, **p < 0.01, ***p < 0.001 versus control (A) and
Cre (B), t test. Scale bar represents 50 mm. See also
Figures S5 and S6.
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Figure 7. Loss of Auts2 Impairs Axon Elongation In Vivo
(A) Contralateral axons projecting from layer II/III neurons in WT and Auts2del8 mutant cerebral cortex at E18.5. Visualization of GFP fluorescence is from vectors
electroporated at E14.5. Yellow arrowheads indicate tips of axonal fibers. The photos were taken with a longer exposure period than the ones in Figure 6 in order
to obtain stronger immunofluorescent signals at extending axons. Graph shows the distance from the tip of axons to midline along the corpus callosum (n = 4).
(B) Primary cortical neurons fromWT andAuts2del8mutant brains electroporated with GFP vector at E15.5. The graph shows the neurite length and the number of
branching points of WT and Auts2del8 mutant individual cortical neuron (each of n > 30 neurons from multiple embryos).
Data are presented as the mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, t test. Scale bars represent (A) 50 mm and (B) 20 mm. See also Figure S7.protein deletion analyses revealed the PR1 domain to be the
essential region for cytoplasmic localization and Rac1 activation.
In this study,wedemonstrated thatAUTS2physiologically func-
tions in cytoplasm for neuronal migration and neuritogenesis
via activation of Rac1. In the loss-of-function experiments
using shRNA in animals and Auts2 mutants (Auts2neo, Auts2del8,
Auts2flox+Cre), cortical neuronal migration was significantly dis-
rupted. As this abnormal migration was rescued by NES-FL-
AUTS2, it suggests that cytoplasmic AUTS2 is involved in cortical
neuronalmigration. Furthermore, as this abnormality could alsobe
rescued by Rac1, it suggests that the AUTS2-Rac1 pathway par-
ticipates in this developmental process. Similarly, in the loss-of-
function studies in vivo and in vitro, neurite extension and branch
formation were impaired, which were also rescued by Rac1. This
suggests that the AUTS2-Rac1 pathway is also physiologically
involved in neuritogenesis. As previous studies have demon-
strated, a variety of Rac-GEFs, including P-Rex1, STEF, Tiam1,
andElmo2/Dock180 complex, are involved inRac1activationdur-
ing neural development (Buchsbaum, 2007; Matsuo et al., 2003;
Yoshizawa et al., 2005). We found in this study that AUTS2 is2176 Cell Reports 9, 2166–2179, December 24, 2014 ª2014 The Autinvolved in Rac1 activation via P-Rex1 and the Elmo2/Dock180
complex, but not STEF or Tiam1, for the lamellipodia formation
inN1E-115 cells. However, the enhancement of neurite elongation
in primary neurons by AUTS2 expression is specifically mediated
by the Elmo2/Dock180 complex. These results suggested that
several Rac-GEFs differentially or cooperatively participate in
Rac1 activation to promote neuronal migration and neurite
outgrowth. Interestingly, Yang et al. (2012) previously reported
that overexpression of WT-Rac1 dramatically promoted cortical
neuronal migration. Taken together, these results suggest that
overexpression of WT-Rac1 increases the basal level of the acti-
vated-form of Rac1 that is likely mediated through AUTS2-inde-
pendent Rac-signaling pathways such as STEF and Tiam1 and
that it may compensate for the downregulation of Rac1 activation
by disruption of AUTS2-Rac1 signaling pathways in Auts2-defi-
cient neurons for neuronal migration and neurite outgrowth. On
theother hand, neither impairedmigration nor axonogenesiscould
be rescued by DN-Cdc42, implying that the Cdc42-suppressing
ability of AUTS2 does not physiologically play an important role
in neuronal migration or neuritogenesis.hors
In the Auts2 knockdown brains, we realized that the twisted
and irregular morphology of the leading process of migrating
neurons (Figure 5B) resembled that of migrating neurons in
which JNK function is suppressed (Kawauchi et al., 2003). As
JNK controls leading processmorphology by regulatingmicrotu-
bule dynamics via phosphorylation of MAP1B (Kawauchi et al.,
2003), a similar regulatory machinery for leading process
morphologymight exist downstream of AUTS2-Rac1, in addition
to the regulatorymachinery for actin cytoskeleton (Kawauchi and
Hoshino, 2008).
We did not observe abnormal apoptosis or proliferation of cells
in any of theAuts2mutant brains (Auts2neo/neo andAuts2del8/del8),
in contrast to what was observed in Auts2 knockdown zebrafish
embryos (Beunders et al., 2013; Oksenberg et al., 2013). Another
discrepancy between mouse and zebrafish AUTS2 is the loca-
tion of the functional domain. While RP1 is the central functional
domain of mouse AUTS2 for regulating actin cytoskeleton and
Rac1 activity, the zebrafish functional domain seems to be the
C-terminal region that does not contain the RP1. These findings
imply that the molecular function of AUTS2 is different between
mammals and fish. It is also possible that theC-terminal region of
mouse AUTS2 may have a function other than regulation of actin
dynamics and Rac1.
In conjunction with the predicted AUTS2 structure, our
immunoblot analyses and 50 RACE experiments suggested the
existence of short isoforms (variants 1 and 2), which lack the
functional PR1-containing N-terminal region. We observed
impairment of neuronal migration and neuritogenesis not only
in Auts2neo/neo but also in Auts2del8/del8 animals where a short
isoform of AUTS2 is maintained. This also confirms that the crit-
ical region for neuronal migration and neuritogenesis resides in
the RP1-containing N-terminal region. We cannot exclude the
possibility that the C-terminal region or the short isoform may
have other functions, probably in nuclei, such as cell proliferation
or differentiation because AUTS2 short isoform exclusively local-
izes in the nuclei. It will be interesting in future work to elucidate
the molecular function of nucleic AUTS2 in brain development.
Individuals with heterozygotic disruptions of the human
AUTS2 gene occasionally present with brain malformations,
including corpus callosum hypoplasia, in addition to psychiatric
phenotypes (Kalscheuer et al., 2007; Oksenberg and Ahituv,
2013). Consistent with human cases, Auts2 heterozygotic
mutant mice also exhibit developmental defects, such as ab-
normal neuronal migration and neuritogenesis. Therefore, our
mutant Auts2mouse lines represent good animal models for hu-
man psychiatric disorders with AUTS2 mutations. Further ana-
lyses of the mouse mutants should help us to understand better
the physiological function of Auts2 in brain development and the
pathology of the AUTS2-related psychiatric diseases.
EXPERIMENTAL PROCEDURES
Experimental Animals
All animal experiments in this study have been approved by the Animal Care
and Use Committee of the National Institute of Neuroscience, Japan, and
the guidelines established by the Institutional Animal Care and Use Committee
of Nagoya University, the Guiding Principles for the Care and Use of Labora-
tory Animals approved by the Japanese Pharmacological Society, and the
NIH Guide for the Care and Use of Laboratory Animals.Cell ReIn Utero Electroporation
ICR pregnant mice were purchased from SLC Japan. In utero electroporation
experiments were performed as described previously (Kawauchi et al., 2003).
pmU6-Auts2 or scramble shRNA vector (0.52 mg/ml) was cotransfected with
pEGFP (0.5 mg/ml) (Kawauchi et al., 2003). To perform the rescue experiments
in Figure 6B, pCAG-Cre (1.25 mg/ml) and the indicated expression plasmids
(0.11.25 mg/ml) were cotransfected with pEGFP.
Primary Culture of Cortical and Hippocampal Neurons
At E16.5, cortices and hippocampi were dissected from ICR mice or Auts2del8
mutant and WT mouse embryos that had been electroporated at E15.5 and
treated with 0.25% trypsin-EDTA in Hank’s balanced salt solution (Sigma)
for 15 min at 37C. The dissociated neurons were plated at a density of
7,500–10,000 cells/cm2 on cover glasses coated with 1 mg/ml poly-L-lysine
(Sigma) and maintained in modified Eagle’s medium containing 2% B27
supplement (Invitrogen). Neurons were electroporated with the expression
plasmids using the NEPA21 electroporator (Nepa Gene) according to the
manufacturer’s instructions.
GTPase Pull-Down Assay
Rac1/Cdc42 pull-down assays were performed as described previously
(Matsuo et al., 2003). Briefly, the active, GTP-bound form of Rac1 or
Cdc42 was pulled down from the cell lysates with 20 mg of PAK-GST
proteins beads (Cytoskeleton). Bound GTP-Rac1 and -Cdc42 proteins
were detected by western blotting using anti-Rac1 (ARC03; Cytoskeleton)
and anti-Cdc42 (610928; BD Transduction Labs), respectively. Densitometry
analysis was performed with ImageJ free image analysis software (NIH),
and relative small GTPase activity was determined by the amount of GTP-
bound Rac1 or Cdc42 bound to PAK-GST protein beads normalized to the
amount of total Rac1 or Cdc42 in cell lysates, respectively. Statistical signif-
icance was established by Student’s t test using GraphPad Prism 5.0
Software.
Immunofluorescence
Embryos at E12.5 and E14.5 were dissected in ice-cold PBS and fixed in 4%
paraformaldehyde (PFA) for 2 hr at 4C. For E18.5 and postnatal brains, tissues
were fixed with 4% PFA at 4C overnight. Fixed embryos and dissected tis-
sues were cryoprotected by overnight immersion in 30% sucrose in PBS,
embedded in optimum cutting temperature (Tissue-Tek O.C.T. compound)
and cryosectioned at 1420 mm. For Immunocytochemistry, cells were fixed
with 4% PFA for 20 min at room temperature. Immunofluorescence was
performed using the following antibodies: rabbit anti-AUTS2 (1:300;
HPA000390; Sigma-Aldrich), goat anti-AUTS2 (1:300; EB09003; Everest
Biotech), mouse anti-b-III tubulin (Tu-20) (1:500; Millipore/Chemicon), goat
anti-doublecortin (C-18) (1:200; sc-8068; Santa Cruz), anti-Cux1 (M-222)
(1:3,000; sc-13024; Santa Cruz), anti-Ctip2 (1:5,000; ab18465; Abcam), rabbit
anti-glutaminase (Hoshino et al., 2005) (1:500), mouse anti-HuC/D (16A11)
(1:500; Invitrogen), rat anti-Ki67 (1:50; 14-5698; eBioscience), rabbit anti-
GABA (1:500; A2052; Sigma-Aldrich), rabbit anti-active-JNK (1:200: V793A;
Promega), rat anti-GFP (RQ1) (1:100; gift from A. Imura, BRI, Kobe), rabbit
anti-cleaved Caspase3 (1:500; 9661S; Cell Signaling), rabbit anti-Intersectin
1 (LS-C186666; LifeSpan BioSciences), and rabbit anti-Intersectin 2 (bs-
13646R; Bioss). For immunohistochemical analysis including in utero electro-
poration experiments, we used the somatosensory cortex area in the coronal
sections between the level of caudal half of caudate putamen in which the
corpus callosum fully appears, and the sections just before the hippocampus
starts to appear. Fluorescence imaging, cell counts, and measurement of neu-
rite length were carried out using a Zeiss LSM 780 confocal microscope sys-
tem (Carl Zeiss) and ZEN 2009 software (Carl Zeiss) or Keyence All-in-One
fluorescence microscope (BZ-X700).
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